Menu
Recruiting NCT06630728

Addiction Potential of Very Low Nicotine Filtered Little Cigars

Phase IV Interventional Smoking (Tobacco) Addiction

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Reduced Nicotine Content Cigars, Normal nicotine content cigar, Usual brand cigar.
Who it may be relevant to
Registry conditions: Smoking (Tobacco) Addiction. Basic parameters: 21 years — 75 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The goal of this clinical trial is to learn how reducing the nicotine content in filtered little cigars can affect the the use of these cigars and lung health in current adult filtered little cigar users. The main question\[s\] it aims to answer are: Are puffing behaviors, appeal/satisfaction, craving suppression, pharmacokinetic effects, and demand similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars? Are health effects and toxicant exposure similar between the regular cigars smoked by participants, normal nicotine study cigars and very low nicotine study cigars? Participants will attend three study visits at OSU. Each visit would last up to 4 hours. During visits, they will * fill several surveys * provide blood samples * perform breathing tests * complete smoking sessions using either their own cigars or the study cigars.

Interventions

  • Drug Reduced Nicotine Content Cigars
    Participants will smoke a very low nicotine content filtered little cigar containing 0.50mg nicotine per gram of tobacco
  • Drug Normal nicotine content cigar
    Participants will smoke a normal nicotine content filtered little cigar containing 5.17mg nicotine per gram of tobacco
  • Drug Usual brand cigar
    Participants will smoke their usual brand filtered little cigar

Primary outcome measures

  • Drug self-administration- Puff topography- total puff volume [Time frame: During session 65 minute puffing session]
  • Forced expiratory volume in 1 second [Time frame: Change from 0 to 65 minutes]
  • Nicotine [Time frame: Change from 0 to 5 minutes]
  • Nicotine [Time frame: Change from 0 to 65 minutes]
  • Carbon monoxide boost [Time frame: Change from 0 to 5 minutes]
  • Carbon monoxide boost [Time frame: Change from 0 to 65 minutes]
Secondary outcome measures (10)
  • Functional residual capacity [Time frame: Change from 0 to 65 minutes]
  • Airway resistance (R5) [Time frame: Change from 0 to 65 minutes]
  • Airway resistance (R5-R20) [Time frame: Change from 0 to 65 minutes]
  • Modified Cigarette Evaluation Scale [Time frame: 65 minutes]
  • Questionnaire on Smoking Urges (Tiffany Drobes) [Time frame: Change from 0 to 5 minutes]
  • Questionnaire on Smoking Urges (Tiffany Drobes) [Time frame: Change from 0 to 65 minutes]
  • Minnesota Nicotine Withdrawal Scale [Time frame: Change from 0 to 5 minutes]
  • Minnesota Nicotine Withdrawal Scale [Time frame: Change from 0 to 65 minutes]
  • Hypothetical purchase task [Time frame: 65 minutes]
  • Cross-price task [Time frame: 65 minutes]

Eligibility criteria

Inclusion criteria

  • Smokers: 1) self-reported regular current filtered little cigars, cigarillos, little cigars, or small cigars use for the past 3 months; regular use will be defined as >=8 cigars smoked per month based on data showing median cigarillo use is 7.5 times per month and median FLC use is 14 times per month 59. We will attempt to bring in heavier users if feasible during recruitment; or 2) Cigarette smokers (>=8d/month for at least 3 months) with either (i) co-use of filtered little cigars, cigarillos, little cigars, or small cigars (at least once in their lifetime) or (ii) answering "yes" to the question "If all cigarettes were taken off the market, would you consider switching to filtered little cigars?"
  • willing to abstain from all tobacco and nicotine for at least 12 hours prior to lab sessions
  • Willing to bring their own, preferred brand little cigars/ small cigars/ cigarillos/ filtered little cigars to smoke in the lab on the first study visit
  • capable of and willing to provide written informed consent
  • read and speak in English.

Exclusion criteria

  • Self-reported significant current lung disease (e.g. asthma, COPD, cystic fibrosis, pulmonary fibrosis); exercise-induced asthma, seasonal allergies for which a patient takes inhalers are allowed
  • History of diagnosis or treatment for lung cancer
  • Self-reported serious or uncontrolled kidney disease, liver disease, metabolic disease (thyroid, diabetes)
  • History of cardiac event or distress within the past 3 months
  • Unstable or significant psychiatric conditions (past and stable conditions will be allowed)
  • Substance use disorders besides nicotine addiction
  • Regular use of other tobacco products besides cigarettes such as snuff, chewing tobacco, snus, e-cigarettes >10d per month
  • Exclusive large or premium cigar users
  • Use of blunts every time or most of the time
  • Regular use of cannabis >10d per month
  • Planning to quit in next 30 days or currently trying to quit or quit attempt in past 30 days
  • Pregnant, delivery in past 12 weeks, breastfeeding, or planning to get pregnant
  • Inability to perform tests or follow instructions during testing

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

United States · 1 center
  • The Ohio State University — Columbus

Identifiers

NCT: NCT06630728 · 2024C0053

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗